{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:52:20Z","timestamp":1789523540713,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s40263-016-0310-2","type":"journal-article","created":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T04:29:38Z","timestamp":1455510578000},"page":"163-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective"],"prefix":"10.1007","volume":"30","author":[{"given":"Thor-Henrik","family":"Brodtkorb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam H.","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Laram\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,15]]},"reference":[{"issue":"8","key":"310_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1478-7547-8-15","volume":"6","author":"PF Gils van","year":"2010","unstructured":"van Gils PF, Hamberg-van Reenen HH, van den Berg M, Tariq L, de Wit GA. The scope of costs in alcohol studies: cost-of-illness studies differ from economic evaluations. Cost Eff Resour Alloc. 2010;6(8):15. doi: 10.1186\/1478-7547-8-15 .","journal-title":"Cost Eff Resour Alloc."},{"key":"310_CR2","unstructured":"Anderson P, Baumberg B. Alcohol in Europe: a public health perspective. In: European Commission Archives. 2006. http:\/\/ec.europa.eu\/health\/archive\/ph_determinants\/life_style\/alcohol\/documents\/alcohol_europe_en.pdf . Accessed 21 Jan 2014."},{"issue":"3","key":"310_CR3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/alcalc\/agt004","volume":"48","author":"P Laram\u00e9e","year":"2013","unstructured":"Laram\u00e9e P, Kusel J, Leonard S, Aubin H-J, Fran\u00e7ois C, Daeppen J-B. The economic burden of alcohol dependence in Europe. Alcohol. 2013;48(3):259\u201369. doi: 10.1093\/alcalc\/agt004 .","journal-title":"Alcohol."},{"key":"310_CR4","unstructured":"Department for Transport. Road causalities: Great Britain 2007. Annual report. In: National Archives. 2007. http:\/\/webarchive.nationalarchives.gov.uk\/20110503151558\/http:\/www.dft.gov.uk\/adobepdf\/162469\/221412\/221549\/227755\/rcgb2007.pdf . Accessed 29 May 2014."},{"key":"310_CR5","unstructured":"Flatley J, Kershaw C, Smith K, Chaplin R, Moon D. Crime in England and Wales 2009\/10. In: Great Britain Home Office. 2010. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/116347\/hosb1210.pdf . Accessed 21 Jan 2014."},{"key":"310_CR6","unstructured":"Institute of Alcohol Studies. Alcohol and the working population. In: Institute of Alcohol Studies. 2009. http:\/\/www.ias.org.uk\/Alcohol-knowledge-centre\/Alcohol-in-the-workplace\/Factsheets\/Alcohol-and-the-working-population.aspx . Accessed 12\u00a0Mar 2015."},{"key":"310_CR7","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.euroneuro.2013.02.006","volume":"23","author":"A Gual","year":"2013","unstructured":"Gual A, He Y, Torup L, van den Brink W, Mann K, ESENSE\u00a02 Study Group. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. Eur Neuropsychopharmacol. 2013;23:1432\u201342.","journal-title":"Eur Neuropsychopharmacol."},{"key":"310_CR8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.biopsych.2012.10.020","volume":"73","author":"K Mann","year":"2013","unstructured":"Mann K, Bladstrom A, Torup L, Gual A, van den Brink W. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biol Psychiatry. 2013;73:706\u201313.","journal-title":"Biol Psychiatry."},{"key":"310_CR9","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/0269881114527362","volume":"28","author":"W Brink van den","year":"2014","unstructured":"van den Brink W, Sorensen P, Torup L, Mann K, Gual A, The SENSE Study Group. Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: a 1-year, randomised controlled study. J Psychopharmacol. 2014;28:733\u201344.","journal-title":"J Psychopharmacol."},{"issue":"9","key":"310_CR10","doi-asserted-by":"crossref","first-page":"e005376","DOI":"10.1136\/bmjopen-2014-005376","volume":"4","author":"P Laram\u00e9e","year":"2014","unstructured":"Laram\u00e9e P, Brodtkorb T-H, Rahhali N, Knight C, Barbosa C, Fran\u00e7ois C, Toumi M, Daeppen J-B. The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high\/very high drinking risk levels: a Markov model. BMJ Open. 2014;4(9):e005376. doi: 10.1136\/bmjopen-2014-005376 .","journal-title":"BMJ Open."},{"key":"310_CR11","unstructured":"National Institute for Health and Care Excellence. Nalmefene for reducing alcohol consumption in people with alcohol dependence. NICE technology appraisal guidance (TA325). In: National Institute for Health and Care Excellence. November 2014. https:\/\/www.nice.org.uk\/guidance\/ta325 . Accessed 10 Mar 2015."},{"key":"310_CR12","unstructured":"National Institute for Health and Care Excellence. Single technology appraisal: nalmefene for reducing alcohol consumption in people with alcohol dependence. Final scope. In: National Institute for Health and Care Excellence. 2014. http:\/\/www.nice.org.uk\/guidance\/ta325\/documents\/alcohol-dependence-nalmefene-final-scope2 . Accessed 10 Mar 2015."},{"key":"310_CR13","unstructured":"National Institute for Health and Care Excellence. Clinical guidelines CG115. Alcohol dependence and harmful alcohol use. In: National Institute for Health and Care Excellence. 2011. http:\/\/www.nice.org.uk\/guidance\/cg115\/resources\/guidance-alcoholuse-disorders-diagnosis-assessment-and-management-of-harmful-drinking-and-alcohol-dependence-pdf . Accessed 12 Mar 2015."},{"key":"310_CR14","doi-asserted-by":"crossref","unstructured":"van den Brink W, Aubin HJ, Bladstr\u00f6m A, Torup L, Gual A, Mann K. Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studies. Alcohol Alcohol. 2013;48(5):570\u20138.","DOI":"10.1093\/alcalc\/agt061"},{"key":"310_CR15","unstructured":"Committee for Medicinal Products for Human Use. European public assessment report: nalmefene. In: European Medicines Agency. 2014. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Summary_for_the_public\/human\/002583\/WC500140303.pdf . Accessed 12 Mar 2015."},{"key":"310_CR16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00131746-200603000-00003","volume":"12","author":"AN Starosta","year":"2006","unstructured":"Starosta AN, Leeman RF, Volpicelli JR. The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders. J Psychiatr Pract. 2006;12:80.","journal-title":"J Psychiatr Pract."},{"key":"310_CR17","unstructured":"World Health Organization, Department of Mental Health and Substance Dependence, Noncommunicable Diseases and Mental Health Cluster. International guide for monitoring alcohol consumption and related harm. In: World Health Organization. 2000. http:\/\/whqlibdoc.who.int\/hq\/2000\/who_msd_msb_00.4.pdf . Accessed 12 Mar 2015."},{"issue":"10","key":"310_CR18","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/hec.3105","volume":"24","author":"A Brennan","year":"2015","unstructured":"Brennan A, Meier P, Purshouse R, Rafia R, Meng Y, Hill-Macmanus D, Angus C, Holmes J. The Sheffield Alcohol Policy Model\u2014a mathematical description. Health Econ. 2015;24(10):1368\u201388. doi: 10.1002\/hec.3105 .","journal-title":"Health Econ."},{"key":"310_CR19","unstructured":"Purshouse R, Brennan A, Latimer N, Meng Y, Rafia R, Jackson R, Meier P. Modelling to assess the effectiveness and cost-effectiveness of public health related strategies and interventions to reduce alcohol attributable harm in England using the Sheffield Alcohol Policy Model version\u00a02.0: report to the NICE Public Health Program. In: National Institute for Health and Care Excellence. 2009. http:\/\/guidance.nice.org.uk\/PHG\/21\/EconomicModellingReport\/pdf\/English . Accessed 10 Mar 2015."},{"key":"310_CR20","doi-asserted-by":"crossref","unstructured":"Rehm J, Shield KD, Rehm MX, Gmel G, Frick U. Alcohol consumption, alcohol dependence and attributable burden of disease in Europe. In: Centre for Addiction and Mental Health. 2012. http:\/\/amphoraproject.net\/w2box\/data\/AMPHORA%20Reports\/CAMH_Alcohol_Report_Europe_2012.pdf . Accessed 10 Mar 2015.","DOI":"10.1037\/e506502014-001"},{"key":"310_CR21","unstructured":"Home Office. Research, Development and Statistics Directorate. Offending Surveys and Research, National Centre for Social Research and BMRB. Social research, offending, crime and justice survey, 2005. 3rd edition [database]. Colchester: UK Data Archive. December 2008."},{"key":"310_CR22","unstructured":"Department of Health. Safe, sensible, social\u2014consultation on further action. In: National Archives. 2008. http:\/\/webarchive.nationalarchives.gov.uk\/20130107105354\/http:\/\/www.dh.gov.uk\/en\/Consultations\/Liveconsultations\/DH_086412 . Accessed 29 May 2014."},{"key":"310_CR23","unstructured":"Home Office. The economic and social costs of crime against individuals and households 2003\/04. Online report 30\/05. In: National Archives. 2005. http:\/\/webarchive.nationalarchives.gov.uk\/20100413151441\/http:\/www.homeoffice.gov.uk\/rds\/pdfs05\/rdsolr3005.pdf . Accessed 5 Jun 2014."},{"key":"310_CR24","unstructured":"Brand S, Price R. Home office research study\u00a0217. The economic and social costs of crime. In: National Archives. 2000. http:\/\/webarchive.nationalarchives.gov.uk\/20110218135832\/rds.homeoffice.gov.uk\/rds\/pdfs\/hors217.pdf . Accessed 17 Mar 2015."},{"key":"310_CR25","unstructured":"Dubourg R, Hamed J, Thorns J. The economic and social costs of crime against individuals and households 2003\/04. Home office online report\u00a030\/05. In: National Archives. 2005. http:\/\/webarchive.nationalarchives.gov.uk\/20100413151441\/http:\/www.homeoffice.gov.uk\/rds\/pdfs05\/rdsolr3005.pdf . Accessed 17 Mar 2015."},{"key":"310_CR26","unstructured":"Office for National Statistics. Consumer price inflation, December 2013. In: Office for National Statistics. 2014. http:\/\/www.ons.gov.uk\/ons\/rel\/cpi\/consumer-price-indices\/december-2013\/index.html . Accessed 18 Feb 2015."},{"issue":"2","key":"310_CR27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hec.816","volume":"13","author":"Z MacDonald","year":"2004","unstructured":"MacDonald Z, Shields MA. Does problem drinking affect employment? Evidence from England. Health Econ. 2004;13(2):139\u201355.","journal-title":"Health Econ."},{"issue":"22","key":"310_CR28","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1080\/00036846.2011.566206","volume":"44","author":"J Jarl","year":"2012","unstructured":"Jarl J, Gerdtham U-G. Does drinking affect long-term sickness absence? A sample selection approach correcting for employment and accounting for drinking history. Appl Econ. 2012;44(22):2811\u201325.","journal-title":"Appl Econ."},{"issue":"5","key":"310_CR29","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1360-0443.2008.02154.x","volume":"103","author":"AM Roche","year":"2008","unstructured":"Roche AM, Pidd K, Berry JG, Harrison JE. Workers\u2019 drinking patterns: the impact on absenteeism in the Australian work-place. Addiction. 2008;103(5):738\u201348.","journal-title":"Addiction."},{"issue":"21","key":"310_CR30","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1080\/00036840903357421","volume":"43","author":"MT French","year":"2011","unstructured":"French MT, Maclean JC, Sindelar JL, Fang H. The morning after: alcohol misuse and employment problems. Appl Econ. 2011;43(21):2705\u201320.","journal-title":"Appl Econ."},{"key":"310_CR31","unstructured":"Cabinet Office Strategy Unit. Alcohol misuse: how much does it cost? In: Societ\u00e0 Italiana di Alcologia. 2003. http:\/\/sia.dfc.unifi.it\/costi%20uk.pdf . Accessed 17 Mar 2015."},{"key":"310_CR32","unstructured":"Office for National Statistics. Labour market statistics 2014. In: Office for National Statistics. 2014. http:\/\/www.ons.gov.uk\/ons\/rel\/lms\/labour-market-statistics\/january-2014\/index.html . Accessed 18 Feb 2015."},{"key":"310_CR33","unstructured":"Office for National Statistics. Full report: sickness absence in the labour market, February 2014. In: Office for National Statistics. 2014. http:\/\/www.ons.gov.uk\/ons\/dcp171776_353899.pdf . Accessed 18 Feb 2015."},{"key":"310_CR34","unstructured":"Office for National Statistics. Annual survey of hours and earnings, 2012 revised results. In: Office for National Statistics. 2013. http:\/\/www.ons.gov.uk\/ons\/publications\/re-reference-tables.html?edition=tcm%3A77-328218 . Accessed 18 Feb 2015."},{"issue":"11","key":"310_CR35","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-154-11-201106070-00008","volume":"154","author":"D Wonderling","year":"2011","unstructured":"Wonderling D, Sawyer L, Fenu E, Lovibond K, Laram\u00e9e P. National Clinical Guideline Centre cost-effectiveness assessment for the National Institute for Health and Clinical Excellence. Ann Intern Med. 2011;154(11):758\u201365.","journal-title":"Ann Intern Med."},{"key":"310_CR36","unstructured":"National Health Service. Reference cost database. Elective inpatient HRG data; currency code DZ11A, DZ11B, DZ11C, DZ23A, DZ23B, DZ23C. In: Gov.UK, 2010\u20132011. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/215298\/dh_131145.xls . Accessed 12 Mar 2015."},{"key":"310_CR37","unstructured":"Personal Social Services Research Unit. Unit costs of health and social care. In: Personal Social Services Research Unit. 2012. http:\/\/www.pssru.ac.uk\/project-pages\/unit-costs\/2012\/index.php?file=full . Accessed 12 Mar 2015."},{"key":"310_CR38","unstructured":"National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. In: National Institute for Health and Care Excellence. April 2013. http:\/\/www.nice.org.uk\/media\/D45\/1E\/GuideToMethodsTechnologyAppraisal2013.pdf . Accessed 5 Jun 2014."},{"key":"310_CR39","doi-asserted-by":"crossref","unstructured":"Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD; ISPOR-SMDM Modeling Good Research Practices Task Force. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6. Value Health. 2012;15(6):835\u201342.","DOI":"10.1016\/j.jval.2012.04.014"},{"issue":"5","key":"310_CR40","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/0272989X12454579","volume":"32","author":"DM Eddy","year":"2012","unstructured":"Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB. Model transparency and validation a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. Med Decis Making. 2012;32(5):733\u201343.","journal-title":"Med Decis Making."},{"key":"310_CR41","unstructured":"National Institute for Health and Care Excellence. Specification for manufacturer\/sponsor submission for Single Technology Appraisal (STA). In: National Institute for Health and Care Excellence. 2013. https:\/\/www.nice.org.uk\/proxy\/?sourceUrl=http%3a%2f%2fwww.nice.org.uk%2fmedia%2fD54%2f6E%2fSpecificationForManufacturerSponsorSubmissionOfEvidenceJune2012.doc . Accessed 12 Mar 2015."},{"key":"310_CR42","unstructured":"National Institute for Health and Care Excellence. NICE technology appraisal guidance [TA325]\u2014nalmefene for reducing alcohol consumption in people with alcohol dependence. In: National Institute for Health and Care Excellence. 2014. https:\/\/www.nice.org.uk\/guidance\/ta325 . Accessed 25 Nov 2014."},{"key":"310_CR43","unstructured":"National Institute for Health and Care Excellence. Final appraisal determination\u2014nalmefene for reducing alcohol consumption in people with alcohol dependence. In: National Institute for Health and Care Excellence. 2014. https:\/\/www.nice.org.uk\/guidance\/gid-tag442\/documents\/alcohol-dependence-nalmefene-id660-final-appraisal-determination-document-2 . Accessed 25 Nov 2014."},{"issue":"1","key":"310_CR44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10479-013-1451-z","volume":"236","author":"A Brennan","year":"2016","unstructured":"Brennan A, Meier P, Purshouse R, Rafia R, Meng Y, Hill-Macmanus D. Developing policy analytics for public health strategy and decisions\u2014the Sheffield Alcohol Policy Model framework. Ann Oper Res. 2016;236(1):149\u201376. doi: 10.1007\/s10479-013-1451-z .","journal-title":"Ann Oper Res."},{"key":"310_CR45","doi-asserted-by":"crossref","unstructured":"Marshall EJ. Adolescent alcohol use: risks and consequences. Alcohol Alcohol. 2014;49(2):160\u20134. doi: 10.1093\/alcalc\/agt180 .","DOI":"10.1093\/alcalc\/agt180"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-016-0310-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-016-0310-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-016-0310-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T15:43:46Z","timestamp":1567611826000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-016-0310-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["310"],"URL":"https:\/\/doi.org\/10.1007\/s40263-016-0310-2","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}